EUVIMEDEUVIMED entdecken
Vergleichsstudie

Linezolid versus vancomycin in vitro activity against methicillin-resistant Staphylococcus aureus biofilms

Perrynaz Ahmed Mahmood Al-Zehhawi, Nihad Taha Mohammed Jaddoa

Microbial Pathogenesis · 2025

DOI: 10.1016/j.micpath.2025.107371 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Microbial Pathogenesis, 2025. Verfasst von Perrynaz Ahmed Mahmood Al-Zehhawi und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, College of Science, University of Baghdad, Baghdad, Iraq. Electronic address: yerinaz.ahmed1702a@sc.uobaghdad.edu.iq. Hauptthemen laut MEDLINE: Biofilms, Linezolid, Methicillin-Resistant Staphylococcus aureus, Vancomycin. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 72 Literaturangaben. Gefördert von: University of Baghdad.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Most microorganisms as well as bacteria live in a community under natural conditions. Bacteria adopted to biofilm mode of life more than 3 billion years ago to survive extreme, harsh environments. They become harmful when they acquire resistance to antibiotics and overcome the standard therapies, which is most commonly found in hospitals. Therefore, many studies have been published regarding antimicrobial resistance (AMR). Staphylococcus aureus is a dangerous pathogen, ubiquitously prevalent as a commensal and opportunistic microorganism in human populations. Methicillin-resistant Staphylococcus aureus (MRSA) is considered one of the major medical problems worldwide since they are frequent colonizers of implanted medical devices causing a variety of hospital-acquired infections. For many years, vancomycin has been the drug of choice for MRSA whereas linezolid is considered the last resort drug. This comparative, cross-sectional study investigated the effects of linezolid on biofilm formation in vitro compared to vancomycin across 85 MRSA isolates. To our knowledge, this is the first study to report high levels of linezolid resistance in MRSA in Iraq. In this brief report, 5 MRSA strains showed resistance to linezolid, with minimum inhibitory concentration (MIC) values of 256 μg/ml. The exact same isolates exhibited vancomycin resistance with MIC values of 1024 μg/ml. All linezolid-resistant MRSA (LR-MRSA) strains demonstrated biofilm formation ability. Additionally, linezolid inhibited the expression of adhesion-related genes cna and clfB. The authors concluded that linezolid exerts a comparable effect to vancomycin in biofilm treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BiofilmsLinezolidMethicillin-Resistant Staphylococcus aureusVancomycinAnti-Bacterial AgentsMicrobial Sensitivity TestsHumansCross-Sectional StudiesStaphylococcal InfectionsDrug Resistance, Bacterial

Stichwörter der Autor:innen

BiofilmLR-MRSALRSLinezolidMRSAMSCRAMMsVancomycin

Substanzen

LinezolidVancomycinAnti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Biology, College of Science, University of Baghdad, Baghdad, Iraq. Electronic address: yerinaz.ahmed1702a@sc.uobaghdad.edu.iq.
  • Department of Biology, College of Science, University of Baghdad, Baghdad, Iraq. Electronic address: Nihad.jaddoa@sc.uobaghdad.ed.iq.

Förderung

  • University of Baghdad

Zitieren

APA

Al-Zehhawi, P. A. M., & Mohammed Jaddoa, N. T. (2025). Linezolid versus vancomycin in vitro activity against methicillin-resistant Staphylococcus aureus biofilms. Microbial Pathogenesis. https://doi.org/10.1016/j.micpath.2025.107371

Vancouver

Al-Zehhawi PAM, Mohammed Jaddoa NT. Linezolid versus vancomycin in vitro activity against methicillin-resistant Staphylococcus aureus biofilms. Microbial Pathogenesis. 2025. doi:10.1016/j.micpath.2025.107371

BibTeX
@article{AlZehhawi2025,
  author = {Al-Zehhawi, Perrynaz Ahmed Mahmood and Mohammed Jaddoa, Nihad Taha},
  title = {Linezolid versus vancomycin in vitro activity against methicillin-resistant Staphylococcus aureus biofilms},
  journal = {Microbial Pathogenesis},
  year = {2025},
  doi = {10.1016/j.micpath.2025.107371}
}
Kostenlos starten →